Categories Earnings, Energy

Earnings Summary: A snapshot of Ameren’s Q4 2023 financial results

Ameren Corp (NYSE: AEE), a leading public utility holding company, has announced financial results for the fourth quarter of 2023. The company also issued guidance for 2024 earnings and long-term growth.

  • Q4 net income declined to $158 million or $0.60 per share from $163 billion or $0.63 per share a year earlier
  • Total operating revenues decreased to $1.62 billion in the fourth quarter from $2.05 billion a year earlier
  • At $264 million, Q4 operating income was down 4% year-over-year
  • The management expects full-year 2024 earnings per share to be in the range of $4.52 to $4.72
  • At the midpoint of the FY4 guidance, the company expects earnings to grow at a 6% to 8% compound annual rate from 2024 through 2028
  • The multi-year earnings growth is expected to be driven by projected rate base growth of about 8.2% compounded annually from 2023 through 2028

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top